Wanebo, H J <br/><br/>
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Oct 2014 
 - 2036-2041 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdu248  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Carboplatin--administration & dosage<br/>Cetuximab<br/>Chemoradiotherapy<br/>Disease-Free Survival<br/>Drug-Related Side Effects and Adverse Reactions--pathology<br/>Epithelial Cells--drug effects<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage